Cardiotoxicity From Human Epidermal Growth Factor Receptor‐2 (HER2) Targeted Therapies

Journal of the American Heart Association

  ^{1    2    2    2} 

[1] Breast and Ovarian Cancer Program, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD;Division of Cardiology, Johns Hopkins University, Baltimore, MD;

关键词: breast cancer;    cardiotoxicity;    heart failure;    human epidermal growth factor‐2;    trastuzumab;   

DOI  :  10.1161/JAHA.117.006915

来源: publisher

【 授权许可】

Unknown